Interaction of rheumatoid factor with infectious vaccinia virus-antibody complexes
Gipson, T.G.; Daniels, C.A.; Notkins, A.L.
Journal of Immunology 112(6): 2087-2093
1974
ISSN/ISBN: 0022-1767 PMID: 4207730 Document Number: 71813
Document emailed within 1 workday
Related Documents
Herrmann, D.; Jäger, L.; Hein, G.; Henzgen, M.; Schlenvoigt, G. 1991: IgE rheumatoid factor. Occurrence and diagnostic importance in comparison with IgM rheumatoid factor and circulating immune complexes Journal of Investigational Allergology and Clinical Immunology 1(5): 302-307Sottnek, H.M.; Cassel, W.A.; Campbell, W.G. 1975: The pathogenesis of Vaccinia virus toxicity. I. the role of virus-platelet interaction Laboratory Investigation; a Journal of Technical Methods and Pathology 33(5): 514-521
Taylor, R.P.; Kujala, G.; Edberg, J.C.; Foreman, P.; Davis, J.S.; Wright, E. 1986: The kinetics of clearance of human antibody/dsDNA immune complexes from rabbit circulation. Effects of dsDNA size, rheumatoid factor, and reduction and alkylation of the antibodies Journal of Immunology 136(10): 3785-3792
Cherney, T.M.; Schultz, R.D. 1996: Viral status and antibody response in cattle inoculated with recombinant bovine leukemia virus-vaccinia virus vaccines after challenge exposure with bovine leukemia virus-infected lymphocytes American Journal of Veterinary Research 57(6): 812-818
Elson, C.J.; Carter, S.D.; Cottrell, B.J.; Scott, D.G.; Bacon, P.A.; Wallington, T.B. 1985: Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis Clinical and Experimental Immunology 59(2): 285-292
Abdullah, N.A.; Torres, B.A.; Basu, M.; Johnson, H.M. 1989: Differential effects of epidermal growth factor, transforming growth factor-alpha, and vaccinia virus growth factor in the positive regulation of IFN-gamma production Journal of Immunology 143(1): 113-117
Plachcińska, J.; Dowjat, K. 1976: Evaluation of measurements of infectious titers of the vaccinia virus in passaged human embryonic fibroblasts Archivum Immunologiae et Therapiae Experimentalis 24(1): 63-68
Austin, R.M.; Daniels, C.A. 1976: Inhibition by rheumatoid factor, anti-FC, and staphylococcal protein a of antibody-dependent cell-mediated cytolysis against Herpes simplex virus-infected cells Journal of Immunology 117(2): 602-607
Winfield, J.B.; Shaw, M.; Taylor, R.P.; Eisenberg, R.A. 1981: Nature of double-stranded DNA binding activity in seropositive rheumatoid arthritis: formation of low avidity DNA/rheumatoid factor/IgG/low density lipoprotein complexes Journal of Immunology 126(4): 1596-1602
Topa, P.K.; Rao, K.V. 1976: Extraction of vaccinia virus and purification of vaccinia elementary body suspension with Mafron 11 Indian Journal of Medical Research 64(10): 1421-1431
Sun, J.; Zhang, Y.; Liu, L.; Liu, G. 2014: Diagnostic accuracy of combined tests of anti cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis: a meta-analysis Clinical and Experimental Rheumatology 32(1): 11-21
Yamane, T.; Hashiramoto, A.; Tanaka, Y.; Tsumiyama, K.; Miura, Y.; Shiozawa, K.; Chihara, K.; Shiozawa, S. 2008: Easy and accurate diagnosis of rheumatoid arthritis using anti-cyclic citrullinated peptide 2 antibody, swollen joint count, and C-reactive protein/rheumatoid factor Journal of Rheumatology 35(3): 414-420
Hidaka, Y. 2010: Measurement of immune complexes: monoclonal rheumatoid factor method Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 6): 119-121
Pope, R.M.; Yoshinoya, S.; McDuffy, S.J. 1981: Detection of immune complexes and their relationship to rheumatoid factor in a variety of autoimmune disorders Clinical and Experimental Immunology 46(2): 259-267
Suzuki, Y.; Oite, T.; Shimizu, F.; Yamamoto, K.; Suzuki, S.; Arakawa, M. 1984: Solubilization of immune complex deposits by native 7S IgG molecules in lupus glomerulonephritis--a possible antigen excess effect on rheumatoid factor-IgG complexes Clinical and Experimental Immunology 58(3): 663-671
Moore, T.L.; Dorner, R.W.; Sheridan, P.W.; Zuckner, J. 1984: Precipitation of 19S IgM rheumatoid factor-IgG circulating immune complexes in patients with juvenile arthritis by polyethylene glycol and separation by immobilized protein a Clinical and Experimental Immunology 56(2): 247-252
Kretzschmar, C. 1983: Eradicability of infectious bovine rhinotracheitis (IBR)/infectious pustular vulvovaginitis (IPV) virus infection. 2. Studies of the virus latency of Riems IBR/IPV vaccine (live viral vaccine) virus strain and field virus following infection of immunized animals Archiv für Experimentelle Veterinarmedizin 37(6): 829-835
Keystone, E.C.; Budz-Tymkewycz, S.; Toews, M.; Lau, C. 1987: Origin of defective T lymphocyte-suppressor activating factor interaction in patients with rheumatoid arthritis Clinical and Experimental Immunology 69(1): 48-56
Reynolds, R.M.; Tan, P.L.; Caughey, D.E. 1981: Variation in rheumatoid factor and antinuclear antibody assays in Auckland laboratories New Zealand Medical Journal 94(689): 84-87
Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571